VISTELA Trademark
Trademark Overview
On Thursday, October 3, 2002, a trademark application was filed for VISTELA with the United States Patent and Trademark Office. The USPTO has given the VISTELA trademark a serial number of 78170595. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Tuesday, December 2, 2003. This trademark is owned by Pfizer Inc.. The VISTELA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, opthalmological preparations
General Information
Serial Number | 78170595 |
Word Mark | VISTELA |
Filing Date | Thursday, October 3, 2002 |
Status | 604 - ABANDONED - AFTER INTER-PARTES DECISION |
Status Date | Tuesday, December 2, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 13, 2003 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, opthalmological preparations |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 8 - Abandoned |
Class Status Date | Tuesday, December 2, 2003 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Pfizer Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Party Name | Pfizer Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Trademark Events
Event Date | Event Description |
Monday, April 19, 2004 | OPPOSITION TERMINATED NO. 999999 |
Monday, January 5, 2004 | OPPOSITION TERMINATED NO. 999999 |
Monday, December 8, 2003 | OPPOSITION TERMINATED NO. 999999 |
Tuesday, December 2, 2003 | ABANDONMENT - AFTER INTER PARTES DECISION |
Thursday, October 30, 2003 | OPPOSITION TERMINATED NO. 999999 |
Thursday, October 30, 2003 | OPPOSITION TERMINATED NO. 999999 |
Thursday, October 30, 2003 | OPPOSITION DISMISSED NO. 999999 |
Friday, July 11, 2003 | OPPOSITION INSTITUTED NO. 999999 |
Friday, June 13, 2003 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, May 13, 2003 | PUBLISHED FOR OPPOSITION |
Wednesday, April 23, 2003 | NOTICE OF PUBLICATION |
Tuesday, March 18, 2003 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, March 10, 2003 | ASSIGNED TO EXAMINER |